Cannabinoids Market Size & Share 2022 to 2030

Market Size by Type (Cannabidiol, Cannabinol, Cannabigerol, Cannabidiolic Acid), by Product (CBD Isolate, CBD Oil), by Application (Pharmaceutical, Food & Beverages, Cosmetics) & Global Forecast.
Report ID: GMI5320
   |
Published Date: September 2022
 | 
Report Format: PDF

Download Free PDF

Cannabinoids Market Size

Cannabinoids Market size was worth more than USD 11.5 billion in 2021 and is expected to grow at a CAGR of more than 20% through 2030. Increasing demand for CBD products due to their health benefits will push the overall market growth.
 

Cannabinoids Market

The cannabinoids industry is expanding rapidly driven by the product’s incredible health benefits, including therapeutic capabilities and its use in veterinary medicines. The medicinal characteristics of Phytocannabinoids found in the cannabis plant in addition to the primary ingredient 9-Tetrahydrocannabinol (THC) have come to light recently; products such as cannabidiol (CBD), cannabigerol (CBG), and tetrahydrocannabivarin (THCV) are consequently receiving a lot of interest. Owing to the numerous uses of cannabinoids, the demand for personal care products such as body lotions, oils, and capsules has skyrocketed. Vaping items and their rising popularity among young people due to the latest trends have also contributed to the market revenue.
 

 

Cannabinoids Market Trends

The growing use of cannabinoids, including CBD-based products for medical ailments will accelerate the industry expansion. Several pharmaceutical firms are deploying cannabis to alleviate pain and diseases such as asthma. Primarily triggered by the implementation of the Farm Bill in the U.S., there has been an exponential growth in the cannabinoids market given the product’s ability to manage anxiety, seizures, muscle disorders, and Parkinson’s disease, among others.
 

Sales of fake and synthetic products may restrain the market size

The rising demand for cannabidiol products has made it possible for illegal manufacturers to develop similar fake goods devoid of cannabis extracts, which will have a negative effect on the cannabinoids market expansion. These synthetic products instead contain chemical compounds that produce similar effects comparable to those of cannabidiol or cannabinol while also having adverse effects on the body. For instance, In February 2020, more than 2,800 patients were hospitalized of which over 68 fatalities were recorded in the US alone, resulting from the adverse effects of e-cigarette, vaping, and use-associated lung injury (EVALI).
 

Cannabinoids Market Analysis

Cannabinoids Market Share By Type

The cannabinoids market is segmented by type into cannabidiol (CBD), cannabinol (CBN), cannabigerol (CBG), and cannabidiolic Acid (CBDA). The CBD segment is further sub-segmented into product and application; including the product categories CBD oil and CBD isolate and the application sub-segments of cosmetics, food and drinks, and pharmaceuticals. The CBD oil product segment is further divided into CBD broad spectrum oil and CBD full spectrum oil.
 

The market share is anticipated to rise in the ensuing years owing to the increasing number of people using CBD oil to treat a variety of illnesses, including anxiety, nausea, pain, inflammation, and sleep disorders. Depending on the indication, CBD oil can be simply applied or eaten. Some studies even state that CBD oil may be useful in alleviating cancer-related symptoms and some side effects pertaining to cancer treatment, such as chronic pain and nausea. Cannabidiol (CBD) segment was valued at over USD 9 billion in 2021 and is anticipated to grow significantly during the forecast period.
 

Cannabinoids Market Size By Region

Europe cannabinoids market is anticipated to cross USD 17 billion by 2030. Growing health consciousness among Europeans and increasing awareness of the health benefits linked with the use of cannabinoid products is leading to an increase in the number of market players in the region. Additionally, the number of government approvals for such products is also depicting an upsurge across the European economies, which is predicted to boost the market forecasts.
 

Cannabinoids Market Share

The major players across cannabinoids market include

  • Bedrocan
  • NuLeaf Naturals, LLC
  • Green Roads
  • Global Cannabinoids
  • EXMceuticals Inc.

Other leading companies are

  • Mile High Labs International Inc.
  • Rhizo Sciences
  • Spark CBD

These firms are dedicatedly working on novel product development and marketing tactics to enhance their market presence.
 

For example, EXMceuticals Inc., an emerging bio-sciences company that specializes in the production of distinctive cannabis formulations, teamed up with Global Cannabinoids in May 2021 to market hemp and cannabinoid-based goods.  In order to import, research, refine, and export cannabinoids and cannabis-based goods, the partnership sought to increase EXM’s Portugal hub, and the companies were able to broaden their geographical reach and enhance commercial relationships.
 

Impact of COVID-19 Pandemic

The COVID-19 pandemic affected the production and manufacturing of cannabinoid-based products, including cannabidiol, cannabinol, cannabigerol and cannabidiolic acid. Panic buying situations in the early months of the pandemic were another factor that reduced product popularity, priority, and sales. However, many nations, including the US, Canada, Germany, Argentina, and Portugal saw the production and delivery of CBD as an important service and granted permission for businesses to continue production throughout the pandemic. To that effect, the COVID-19 pandemic has also had a favorable effect on the market expansion.
 

The cannabinoids market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030 for the following segments:

By Type

  • Cannabidiol (CBD)
    • By Product
      • CBD Isolate
      • CBD Oil
        • CBD Full Spectrum Oil
        • CBD Broad Spectrum Oil
      • Others
    • By Application
      • Pharmaceutical
        • Suppository
        • Transdermal Patches
        • Tablets & Capsules
        • Creams & Roll-ons
        • CBD Inhalers
        • Others
      • Food & Beverages
      • Cosmetics
      • Others
  • Cannabinol (CBN)
  • Cannabigerol (CBG)
  • Cannabidiolic Acid (CBDA)
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Switzerland
    • The Netherlands
  • Asia Pacific
    • Australia
    • New Zealand
    • Japan
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Peru
    • Colombia
  • Middle East & Africa
    • South Africa
    • Israel
    • Turkey

 

Authors: Monali Tayade, Jignesh Rawal
Cannabinoids Market Scope
  • Cannabinoids Market Size
  • Cannabinoids Market Trends
  • Cannabinoids Market Analysis
  • Cannabinoids Market Share

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definition

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1   Paid sources

1.4.1.2   Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Cannabinoids industry 3600 synopsis, 2017 - 2030

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Regional trends

Chapter 3   Cannabinoids Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2030

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Rising cannabinoid biosynthesis

3.3.1.2   Growing medical applications

3.3.1.3   Increasing product adoption and utilization owing to government approvals

3.3.1.4   Changing regulatory landscape for approval

3.3.2    Industry pitfalls & challenges

3.3.2.1   Counterfeit & synthetic products penetrating the market

3.3.2.2   Over complicated prescription process especially cannabidiol products

3.4    Growth potential analysis

3.4.1    By type

3.5    COVID-19 impact analysis

3.6    Cannabidiol (CBD) industry volume analysis, by regions, 2021 (Tons)

3.7    Prominent hemp planting countries, 2020 & 2021

3.7.1    By planting area

3.7.2    By output

3.7.3    Average CBD content

3.8    Cost of cultivation & extraction, by region, 2021

3.8.1    U.S.

3.8.2    Europe

3.9    Product pricing analysis, U.S. & Europe, 2021

3.10    Top 10 CBD isolate producers, by revenue, 2021

3.11    Top 10 CBD oil producers, by revenue, 2021

3.12    Supply chain analysis

3.13    Regulatory landscape

3.13.1    U.S.

3.13.2    Europe

3.14    Porter’s analysis

3.15    Competitive landscape, 2021

3.16    PESTEL analysis

Chapter 4   Cannabinoids Market, By Type

4.1    Key segment trends

4.2    Cannabidiol (CBD)

4.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.2    Cannabidiol (CBD), by product

4.2.2.1   CBD isolate

4.2.2.1.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.2.2   CBD oil

4.2.2.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.2.2.2    CBD full spectrum oil

4.2.2.2.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.2.2.3    CBD broad spectrum oil

4.2.2.2.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.2.3   Others

4.2.2.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3    Cannabidiol (CBD), by application

4.2.3.1   Pharmaceutical

4.2.3.1.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.1.2    Suppository

4.2.3.1.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.1.3    Transdermal patches

4.2.3.1.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.1.4    Tablets & capsules

4.2.3.1.4.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.1.5    Creams & roll-ons

4.2.3.1.5.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.1.6    CBD inhalers

4.2.3.1.6.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.1.7    Others

4.2.3.1.7.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.2   Food & beverages

4.2.3.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.3   Cosmetics

4.2.3.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.3.4   Others

4.2.3.4.1    Market size, by region, 2017 - 2030 (USD Million)

4.3    Cannabinol (CBN)

4.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.4    Cannabigerol (CBG)

4.4.1    Market size, by region, 2017 - 2030 (USD Million)

4.5    Cannabidiolic acid (CBDA)

4.5.1    Market size, by region, 2017 - 2030 (USD Million)

4.6    Others

4.6.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 5   Cannabinoids Market, By Region

5.1    Key regional trends

5.2    North America

5.2.1    Market size, by country, 2017 - 2030 (USD Million)

5.2.2    Market size, by type, 2017 - 2030 (USD Million)

5.2.2.1   Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.2.2.1.1    Cannabidiol (CBD) market size, by CBD oil, 2017 - 2030 (USD Million)

5.2.2.2   Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.2.2.2.1    Cannabidiol (CBD) market size, by pharmaceutical, 2017 - 2030 (USD Million)

5.2.3    U.S.

5.2.3.1   Market size, by type, 2017 - 2030 (USD Million)

5.2.3.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.2.3.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.2.3.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.2.3.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.2.4    Canada

5.2.4.1   Market size, by type, 2017 - 2030 (USD Million)

5.2.4.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.2.4.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.2.4.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.2.4.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.3    Europe

5.3.1    Market size, by country, 2017 - 2030 (USD Million)

5.3.2    Market size, by type, 2017 - 2030 (USD Million)

5.3.2.1   Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.3.2.1.1    Cannabidiol (CBD) market size, by CBD oil, 2017 - 2030 (USD Million)

5.3.2.2   Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.3.2.2.1    Cannabidiol (CBD) market size, by pharmaceutical, 2017 - 2030 (USD Million)

5.3.3    Germany

5.3.3.1   Market size, by type, 2017 - 2030 (USD Million)

5.3.3.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.3.3.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.3.3.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.3.3.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.3.4    UK

5.3.4.1   Market size, by type, 2017 - 2030 (USD Million)

5.3.4.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.3.4.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.3.4.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.3.4.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.3.5    France

5.3.5.1   Market size, by type, 2017 - 2030 (USD Million)

5.3.5.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.3.5.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.3.5.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.3.5.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.3.6    Italy

5.3.6.1   Market size, by type, 2017 - 2030 (USD Million)

5.3.6.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.3.6.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.3.6.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.3.6.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.3.7    Switzerland

5.3.7.1   Market size, by type, 2017 - 2030 (USD Million)

5.3.7.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.3.7.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.3.7.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.3.7.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.3.8    The Netherlands

5.3.8.1   Market size, by type, 2017 - 2030 (USD Million)

5.3.8.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.3.8.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.3.8.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.3.8.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.4    Asia Pacific

5.4.1    Market size, by country, 2017 - 2030 (USD Million)

5.4.2    Market size, by type, 2017 - 2030 (USD Million)

5.4.2.1   Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.4.2.1.1    Cannabidiol (CBD) market size, by CBD oil, 2017 - 2030 (USD Million)

5.4.2.2   Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.4.2.2.1    Cannabidiol (CBD) market size, by pharmaceutical, 2017 - 2030 (USD Million)

5.4.3    Australia

5.4.3.1   Market size, by type, 2017 - 2030 (USD Million)

5.4.3.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.4.3.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.4.3.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.4.3.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.4.4    New Zealand

5.4.4.1   Market size, by type, 2017 - 2030 (USD Million)

5.4.4.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.4.4.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.4.4.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.4.4.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.4.5    Japan

5.4.5.1   Market size, by type, 2017 - 2030 (USD Million)

5.4.5.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.4.5.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.4.5.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.4.5.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.4.6    Thailand

5.4.6.1   Market size, by type, 2017 - 2030 (USD Million)

5.4.6.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.4.6.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.4.6.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.4.6.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.5    Latin America

5.5.1    Market size, by country, 2017 - 2030 (USD Million)

5.5.2    Market size, by type, 2017 - 2030 (USD Million)

5.5.2.1   Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.5.2.1.1    Cannabidiol (CBD) market size, by CBD oil, 2017 - 2030 (USD Million)

5.5.2.2   Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.5.2.2.1    Cannabidiol (CBD) market size, by pharmaceutical, 2017 - 2030 (USD Million)

5.5.3    Brazil

5.5.3.1   Market size, by type, 2017 - 2030 (USD Million)

5.5.3.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.5.3.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.5.3.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.5.3.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.5.4    Mexico

5.5.4.1   Market size, by type, 2017 - 2030 (USD Million)

5.5.4.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.5.4.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.5.4.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.5.4.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.5.5    Peru

5.5.5.1   Market size, by type, 2017 - 2030 (USD Million)

5.5.5.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.5.5.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.5.5.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.5.5.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.5.6    Colombia

5.5.6.1   Market size, by type, 2017 - 2030 (USD Million)

5.5.6.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.5.6.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.5.6.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.5.6.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.6    Middle East & Africa

5.6.1    Market size, by country, 2017 - 2030 (USD Million)

5.6.2    Market size, by type, 2017 - 2030 (USD Million)

5.6.2.1   Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.6.2.1.1    Cannabidiol (CBD) market size, by CBD oil, 2017 - 2030 (USD Million)

5.6.2.2   Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.6.2.2.1    Cannabidiol (CBD) market size, by pharmaceutical, 2017 - 2030 (USD Million)

5.6.3    South Africa

5.6.3.1   Market size, by type, 2017 - 2030 (USD Million)

5.6.3.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.6.3.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.6.3.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.6.3.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.6.4    Israel

5.6.4.1   Market size, by type, 2017 - 2030 (USD Million)

5.6.4.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.6.4.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.6.4.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.6.4.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

5.6.5    Turkey

5.6.5.1   Market size, by type, 2017 - 2030 (USD Million)

5.6.5.1.1    Cannabidiol (CBD) market size, by product, 2017 - 2030 (USD Million)

5.6.5.1.1.1    Cannabidiol (CBD) market size, CBD oil, 2017 - 2030 (USD Million)

5.6.5.1.2    Cannabidiol (CBD) market size, by application, 2017 - 2030 (USD Million)

5.6.5.1.2.1    Cannabidiol (CBD) market size, pharmaceutical, 2017 - 2030 (USD Million)

Chapter 6   Company Profiles

6.1    Competitive dashboard

6.2    Bedrocan

6.2.1    Business overview

6.2.2    Financial data

6.2.3    Product landscape

6.2.4    Strategic outlook

6.2.5    SWOT analysis

6.3    NuLeaf Naturals, LLC

6.3.1    Business overview

6.3.2    Financial data

6.3.3    Product landscape

6.3.4    Strategic outlook

6.3.5    SWOT analysis

6.4    Green Roads

6.4.1    Business overview

6.4.2    Financial data

6.4.3    Product landscape

6.4.4    Strategic outlook

6.4.5    SWOT analysis

6.5    Global Cannabinoids

6.5.1    Business overview

6.5.2    Financial data

6.5.3    Product landscape

6.5.4    Strategic outlook

6.5.5    SWOT analysis

6.6    Maricann, Inc

6.6.1    Business overview

6.6.2    Financial data

6.6.3    Product landscape

6.6.4    Strategic outlook

6.6.5    SWOT analysis

6.7    Mile High Labs International Inc.

6.7.1    Business overview

6.7.2    Financial data

6.7.3    Product landscape

6.7.4    Strategic outlook

6.7.5    SWOT analysis

6.8    Rhizo Sciences

6.8.1    Business overview

6.8.2    Financial data

6.8.3    Product landscape

6.8.4    Strategic outlook

6.8.5    SWOT analysis

6.9    SPARKCBD

6.9.1    Business overview

6.9.2    Financial data

6.9.3    Product landscape

6.9.4    Strategic outlook

6.9.5    SWOT analysis

6.10    Folium Biosciences

6.10.1    Business overview

6.10.2    Financial data

6.10.3    Product landscape

6.10.4    Strategic outlook

6.10.5    SWOT analysis

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

Authors: Monali Tayade, Jignesh Rawal

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore our licensing options:

Starting at: $2,450

Immediate Delivery Available

Premium Report Details

Base Year: 2021

Companies Profiled: 9

Tables and Figures: 321

Countries covered: 19

Pages: 208

Download Free PDF

img

Cannabinoids Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report Cannabinoids Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!